Benzinga | Nov 4, 2021 09:08AM EDT

Albireo Pharma Q3 EPS $(2.03) Misses $(0.38) Estimate, Sales $3.66M Beat $3.48M Estimate

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(2.03) per share which missed the analyst consensus estimate of $(0.38) by 434.21 percent. This is a 3.57 percent decrease over losses of $(1.96) per share from the same period last year. The company reported quarterly sales of $3.66 million which beat the analyst consensus estimate of $3.48 million by 5.29 percent. This is a 71.94 percent increase over sales of $2.13 million the same period last year.